Launched last year, the Trust will again award R1.5 million to local academic research - … Areas of interest will be: Other research focus areas will be considered as to not restrict scientific creativity, Gamma-aminobutyric This brings to 18 the total number of research grants conferred locally by the Trust since its inception. Brilinta/Brilique in CAD-PMI, CAD-T2DM and AIS (acute ischemic stroke). Associate Director, Medical Education Grants Office is responsible and accountable for the development and execution of the US independent medical education strategy for a therapeutic area that aligns with Medical Affairs and Corporate strategic objectives. PLEASE NOTE THAT ASTRAZENECA IS UNABLE TO REVIEW PROPOSALS FOR STUDIES INVOLVING PEMBROLIZUMAB AND LYNPARZA. Studies in patients with SLE focus, including: Assessments of organ disease responses in lupus (e.g. Article Snippet: Shaun Goodman received research grant support and speaker/consulting honoraria from 10.13039/100004325 AstraZeneca , 10.13039/100004326 Bayer , 10.13039/100008021 Bristol Myers Squibb , 10.13039/501100002973 Daiichi-Sankyo , Eli 10.13039/100004312 Lilly , 10.13039/100004334 Merck, and 10.13039/100004339 Sanofi . You are about to access AstraZeneca historic archive material. Find more information about AstraZeneca’s Access 360 and other support programs that are available for healthcare professionals, and learn more about AstraZeneca research and development. AstraZeneca supports fellowships, advanced training and research opportunities for post-doctoral students and healthcare professionals in fields aligned to our core therapeutic areas. Active drug trials with Roxadustat: will only be considered after Roxadustat is authorised in the country of the applicant. To help address the most profound of these challenges, the LCRF-AstraZeneca grant program aims to fund innovative projects to: Understand primary and acquired resistance to osimertinib and novel combinations targeting concurrent driver mutations AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food … One of a number of AstraZeneca’s locations are possible, at the discretion of AstraZeneca. Opportunities for development in Breast cancer: Combinations studies with targeted biological agents: Accepting Externally Sponsored Clinical Research Proposals  for drug only in allogenic stem cell transplantation, EGFR sensitising and T790M Resistance Mutations Inhibitor, Accepting limited number of Externally Sponsored Clinical Research Proposals. Savolitinib monotherapy proposals in MET-driven solid tumours (ie tumours with MET gene amplification, activating MET mutations, MET fusions or HGF amplifications) will be considered in tumour types other than NSCLC, papillary renal cell carcinoma (pRCC), gastric cancer, castration resistant prostate cancer (CRPC) and paediatric brain tumours. This research is the first to examine how a COVID vaccine works on transmission, alongside confirming that the UK approach to administering doses (12 weeks in between as opposed to 3 or 4) is supported by the outcome. As well as joint working with the NHS, AstraZeneca also provides occasional grants to the NHS, affiliated research institutions and other Healthcare Organisations (HCOs). Deadline: October 12, 2020. Individuals may accept and hold only one AACR grant at a time. We’re curious about science and the advancement of knowledge. PUBLISHED 5 February 2019. 2020 has been a difficult year for all, but has seen 58 vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) be developed and in clinical trials,1 with some vaccines reportedly having more than 90% efficacy against COVID-19 in clinical trials. The AstraZeneca Step Up!Global Grants Programme is now open for applications for health promotion programmes running from 2021 to 2022. AstraZeneca strongly believes that interactions with Health Care Providers (HCPs) and Healthcare Organisations (HCOs) positively influence the quality of patient treatment and the value of medical research. Combinations with durvalumab in tumour types other than renal cell carcinoma and NSCLC. It includes donations of medicines in response to public health needs related to national and international disasters and humanitarian crises or as part of free goods Patient Assistance Programmes. Investigate the role of TSLP in different types of respiratory exacerbations (e.g. The Grant seeks to enhance health research capacity in Nigeria by supporting local research that will advance knowledge and improve practice in various specialties As well as joint working with the NHS, AstraZeneca also provides occasional grants to the NHS, affiliated research institutions and other Healthcare Organisations (HCOs). Sequencing strategies and response after progression on anti-androgens, Breast cancer: comparison of Zoladex + Tamoxifen with modern chemo regimens in HR+ pre-menopausal patients in early BC. Special Initiatives and/or Representative Health and Human Services Grants:Connections for Cardiovascular Health SM (CCH)—The AstraZeneca HealthCare Foundation awarded CCH grants to 11 nonprofit organizations in 2018 working to help prevent and/or manage cardiovascular disease by conducting programs for at-risk groups and tailoring activities and information to the needs and … The ASTRO-AstraZeneca Radiation Oncology Research Training Fellowship is a joint effort to provide physician-scientists with real-world experience in late-stage clinical trial development at the facilities of AstraZeneca and its Affiliates. Other AstraZeneca sites: Select your country from our list of global sites … triggers), Investigate mechanism of action of tezepelumab in asthma and effects on airway/structure function and cellular/molecular pathology, Biomarkers of response to inhaled corticosteroid-containing therapies in COPD, Biomarkers to characterize COPD pheno and/or endotypes that benefit from non-ICS-containing therapies, Understand inflammation in COPD vs. non-inflammatory features of the disease (e.g. 1 Lungenclinic, Airway Research Center North, German Center for Lung Research, 22927 - Grosshansdorf/DE; 2 Department Of Clinical Oncology, Chinese University of Hong Kong, Hong Kong/CN; 3 Thoracic Oncology Program, AdventHealth Cancer Institute, 32803 - Orlando/US; 4 Department Of Medical Oncology, Rocky Mountain Cancer Centers, Denver, Co, United States Of America, Department … Educational Sponsorships or Grants that are independent or accredited which focus on education activities and initiatives, such as HCP/scientist and patient education, general support of medical or Scientific, Examples:Conferences, Scientific Forums, Guideline Dissemination Quality Improvement Initiatives, Awards for fellows and young investigators. Such grants are made according to AstraZeneca policy and procedure for projects benefitting patient care and/or medical research. Oral VEGF receptor -1-2-3 kinase inhibitor, Immuno-modulator; a human mAb of the immunoglobulin G1 kappa (IgG1κ) subclass that inhibits binding of Programmed Death Ligand 1 (PD-L1) to PD-1 and CD80, Selective Estrogen Receptor Downregulator. Real-world clinical and economical benefits of budesonide/ formoterol as a reliever across all asthma severities. Proposals for ESR will not be endorsed, unless if a major data gap has been identified, Accepting proposals in Japan and China only. 5m in Grants Being Allocated to Academic Medical Research Monday, 19 January, 2015 The AstraZeneca Research Trust, a non-profitable Trust for the disbursement of academic medical research funding is calling for 2015 research proposals. AstraZeneca is committed to supporting and enabling quality independent medical and scientific education as well as charitable support that will enhance patient care and meets our standards of quality and compliance. Requestors of medical education or research grants should visit the AstraZeneca Request Support webpage for more information on opportunities available through AstraZeneca Pharmaceuticals. No. Grant requests of this type should not be made through the AstraZeneca HealthCare Foundation’s Connections for Cardiovascular Health℠ program. This risk must be considered when proposing a new indication and associated treatment regimen, Given the potential for DDI and LFT effects, dosing regimen (level and duration) as well as inclusion/exclusion criteria should be selected carefully to support a favourable risk-benefit, There is currently no clinical data to support use in pediatric populations below 12 years of age, although existing preclinical data would support clinical studies in a pediatric population of > 5 years, AZD5904 is renally cleared, thus, requiring caution and PK monitoring if dosed to subjects with impaired renal function, Autoimmune diseases that have B cell etiology. Examples:Membership at the AZ level (not individual level), Trade Associations. The compound being studied is an investigational new drug from AstraZeneca that targets GABA (A) receptors. The Lung Cancer Research Foundation (LCRF) today announced a collaboration with AstraZeneca to fund over $900,000 in research grants focused on … Examples:The AstraZeneca Young Health Programme, Donations to Red Cross Disaster Appeals, Charity Fundraiser events. Our contribution to the UK. Understand the impact of COVID-19 vaccination with AZD1222 (COVID-19 AstraZeneca Vaccine) in at-risk groups and vulnerable populations, Sustainability of school-located influenza vaccination programs, Novel approaches to evaluating LAIV-induced immune responses, The reproductive toxicology package indicates a risk of fetal toxicity. Email: Medical.InformationUK@astrazeneca.com . If your program includes educational activities certified for CME/CE for physicians, pharmacists, nurses, and other healthcare professionals, as well as activities without continuing education credit or scientific sponsorships, you will need to apply to AstraZeneca’s Medical Education Grants Office. AstraZeneca research grants travel sponsorship honoraria Research Grants Travel Sponsorship Honoraria, supplied by AstraZeneca, used in various techniques. Proposals will be prioritized accordingly based on scientific merit and fit with the clinical program. The Terribly Inadequate Research Behind the the Oxford-AstraZeneca COVID-19 Vaccine. Mechanistic studies in relevant disease-state models to: Study the effect of eosinophil depletion by benralizumab on airway structure/function and cellular/molecular pathology, Characterise the role and effect of benralizumab on other IL-5R expressing cells beyond eosinophils, Real world studies in eosinophil-driven diseases other than asthma that provide information about patient characteristics and disease burden, Mechanistic or clinical studies in eosinophil-driven diseases other than asthma that are not addressed by currently sponsored development programmes, Studies related to exacerbations and/or suitable patient populations, Impact of first and subsequent exacerbations, Clinical and economic impact of non-severe exacerbations, Identification of patients that are at risk of exacerbation, Evidence supporting the role of triple therapy in symptom improvement, Identification of patients  likely to respond to ICS, Studies related to the clinical/economic benefit of ICS as part of triple therapy, Relationship between safety/tolerability and patient benefit of FDC triple therapy, Clinical/Economic impact of ICS use as an early treatment for COPD, The benefit of pMDI device in patients with COPD, Novel technologies to measure clinical response, including imaging and mechanistic studies, Evidence informing the value proposition of connected device technology, Correlations between SABA use, ICS use and patterns of asthma exacerbations, Mechanisms linking the variability of inflammation, symptoms and exacerbations, Long-term health consequences of intermittent OCS bursts. Tuesday, 4 February 2014. ET. Research to further development of regulatory endpoints in renal trials, Research to support understanding of early disease progression, and how it relates to progression of disease, Research to support understanding of fast progressors versus patients with slower prognoses, Mechanistic and biomarker studies to further novel segmentation of chronic kidney disease, which is not biopsy dependent, Preclinical reprotoxicology data is available and has not identified any specific risks. Employment. As a combination with novel agents for which there is a strong scientific rationale and demonstrable pre-clinical evidence or translational science, with a preference to combining with existing AZ marketed or pipeline products. AstraZeneca has received more than $1 billion from the U.S. Health Department's Biomedical Advanced Research and Development Authority to develop a coronavirus vaccine from the University of Oxford. Please follow the instructions to register a user name and password to access the tool. AstraZeneca Research Grant 2002 ～ バーチャル研究所構想に向けて着実に前進 ～ PUBLISHED 2002年 9月 10日. Grants Provided to Institutions in 2014. Rapid identification of 1L resistance mechanisms using tissue, to accelerate new combination options, Benefit/risk of treatment beyond progression, Understand biomarkers of poor initial response to 1L TAGRISSO, Extend survival benefit using TAGRISSO in combination with  targeted and non-targeted approach’s, Establish evidence to support appropriate position of IO agents in EGFRm patients (advanced and early disease), Generate RWE data on 1L TAGRISSO including patient preference, Develop insights into the 1L treatment journey to reinforce the benefits of starting with the best EGFR TKI first, Assess the risk of CNS disease progression with 1, Develop treatment insights into the early disease setting, including EGFR prevalence through early screening, Build prospective evidence for CNS risk reduction, Build efficacy in leptomeningeal metastases, and symptomatic CNS patients using the 80mg dose, Use of TAGRISSO in combination with Stereotactic radiotherapy, and in combinations with other systemic agents, Translational assessment of tumour micro-environment post-surgery in the neoadjuvant setting, Address optimal treatment strategy for downstaging tumors (e.g. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK. We follow a strict code of ethics which ensures we are compliant with regulations and ethical standards. US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897. Important notice for users StepUp!, part of AstraZeneca’s Young Health global grants programme, aims to extend the reach and impact of AstraZeneca’s investment in young people’s health. Grant requests of this type should not be made through the AstraZeneca HealthCare Foundation’s Connections for Cardiovascular Health℠ program. EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. AstraZeneca Research Grant awarded four exceptional researchers with grants to the tune of over sixteen million naira. Proposals shall be prioritized accordingly based on scientific merit and fit with the core development program. Paediatric NF1-PN That research, which is yet to be peer reviewed, examined the effectiveness of the first dose of the Pfizer and AstraZeneca vaccines in a national study of about 5.4 million people. Grants Provided to Institutions in 2014. Applications for the 2021 Fellowship are no longer being accepted. AstraZeneca is also committed to supporting high quality independent continuing medical education that enhances patient care and meets our standards of quality and compliance. The AACR-AstraZeneca Stimulating Therapeutic Advances through Research Training (START) Grants represent an exciting new initiative to encourage and support such collaboration. Limited to combinations outside of ongoing internal program with strong scientific rationale, HER2-targeting Antibody Drug Conjugate (ADC). Investigators may submit only one application for the AACR-AstraZeneca Immuno-oncology Research Fellowships but may concurrently apply for other AACR grants. ET. SCLC, GI tumours) supported by robust preclinical data may be considered, Priority will be given to proposals that advance understanding of core development programs in NSCLC, Bladder and HNSCC, Pre-clinical studies will be considered through the AstraZeneca, Studies that overlap or compete with AstraZeneca development program or where there is compromised or excessive safety risk will not be accepted, Non-oncology indications will not be supported at this time, First-line for patients with advanced breast cancer after adjuvant AI, Adding novel targeted agents after progression on Faslodex, Peri- and pre-menopausal women as monotherapy or in combination (e.g. Discharge protocols and readmission rates for Emergency Departments, Interventions to overcome reliance on SABA monotherapy during rescue situations, Other respiratory diseases where inflammatory ‘flare ups’ are treated with OCS, Increase present understanding of TSLP-driven inflammation beyond eosinophilic/T2 asthma, Understand the role of TSLP in modulating epithelial health. Value: Up to AUD$75,000 for 1 year. I have read this warning and will not be using any of the contained product information for clinical purposes. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Please utilize our Global RAPID Pre-assessment to determine what application process to follow based on the nature of your proposal. That means we will not use or disclose the information submitted, unless approved in writing by the submitter; or the information becomes public, is separately received or independently developed. acid receptor B (GABAB) agonist, We are currently not accepting any ESRs related to Long Acting Antibodies research, Oral peripherally-acting mu opioid receptor antagonist, Seroquel / Apply today. Medical. What does the Company require from Investigators who request support for ESR? Grants and Donations may be awarded to Healthcare Organisations, Patient Organisations, or … Tenable: Australia, Aotearoa New Zealand or overseas. Of particular interest are autoimmune disease in the areas of neuro-inflammatory, rheumatoid and dermatology, The Company will supply drug only (no funding is available at this time), Please contact company staff before submitting a study proposal. provides grants of up to US$10,000 to help small, innovative, youth-focused non-profits develop and deliver effective health promotion programmes – with an emphasis on under-resourced and marginalised … 5m in Grants Being Allocated to Academic Medical Research Monday, 19 January, 2015 The AstraZeneca Research Trust, a non-profitable Trust for the disbursement of academic medical research funding is calling for 2015 research proposals. Requestors of medical education or research grants should visit the AstraZeneca Request Support webpage for more information on opportunities available through AstraZeneca Pharmaceuticals. Observational Research (i.e. Step Up! All contributions made by AstraZeneca are paid only directly to US-based nonprofit organizations. AstraZeneca provides this link as a service to website visitors. The non-Company researcher should submit either a clinical ESR proposal or a non-clinical ESR protocol. XR (quetiapine Proposals for non-oncological indications may be of interest. AstraZeneca in the UK A global pharmaceutical company with a major UK presence. The AACR-AstraZeneca Stimulating Therapeutic Advances through Research Training (START) Grants represent an exciting new initiative to encourage and support such collaboration. The AACR-AstraZeneca Ovarian Cancer Research Fellowships represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct ovarian cancer research and to establish a successful career path in this field. AstraZeneca is not responsible for the privacy policy of any third party websites. However, side effects listed in section 4 may impact your ability to drive and use machines. The Grant seeks to enhance health research capacity in Nigeria by supporting local research that will advance knowledge and improve practice in various specialties Understand impact of COVID-19 overall burden on communities, spectrum of disease in communities, and level of herd immunity. Mailing List . R1. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more structural changes), Differentiation of COPD exacerbation types (e.g. Our purpose is to push the boundaries of science to deliver life-changing medicines. infectious vs. non-infectious), ICS-containing therapy in early (vs. mild or severe) COPD, in order to prevent disease progression, Role of PDE4 inhibition in COPD-related inflammation, The risk of muscular skeletal syndrome (MSS; joint fibrodysplasia), while reversible, has been seen after chronic administration with other MPP inhibitors in humans and fibrodyplasia in the subcutis has been seen at high doses in the 12 month preclinical safety study with AZD1236. We are engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians. Observational research into routine clinical management of patients with heart failure and cardiovascular risk. Until Lokelma is authorised in the country of the applicant, we need to defer the endorsement of any clinical proposals. Applications for the 2021 Fellowship are no longer being accepted. With a $51,000 grant from FRAXA Research Foundation, Dr. Craig Erickson conducting a double-blind, placebo-controlled clinical trial of AZD7325 in adults ages 18-50 with Fragile X syndrome at Cincinnati Children’s Hospital. Externally Sponsored ‘Non-Clinical’ Research proposals might still be considered but only where sponsors require supply of drug and not funding support. 11-beta-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) inhibitor, Exploring the Effects of Dapagliflozin on the Cardiovascular System, Exploring the Effects of Dapagliflozin on the Renal System, Other research focus areas will be considered so as not to restrict scientific creativity, Accepting proposals in China only (previous confirmation with Xi Zang Kang Zhe Pharmaceutical development Co., Ltd.), Renal disease (no substance or brand involved), Oral, hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). Each fellowship provides a three-year grant of $225,000 to support the salary and benefits of the fellow while working on a mentored cancer research project. Seroquel Sponsorships or Collaborations to advance science and health through genuine medical, science, where AstraZeneca has involvement or receives benefit/recognition, Examples:Congress, Patient Group Support, Collaborative partnerships Collaborations with Health Services to improve health outcomes, Consensus/White Papers/Publications. The World Health Organization (WHO) has given AstraZeneca (AZ) and Oxford University’s COVID-19 vaccine an emergency use listing (EUL) for all adults. Please note, approval of a proposal does not imply or guarantee approval of a protocol. Interventional Clinical Research (Phase I - IV) - involving authorized, unauthorized or discontinued Company compounds no longer being developed. cetuximab, AZ targeted small molecules etc. Monotherapy proposals must have an exceptionally strong rationale to be supported by AZ. AZ opt to become a corporate member of a non political medical association or society.